283 related articles for article (PubMed ID: 37175680)
41. COVID-19 and thrombosis: Clinical features, mechanism of disease, and therapeutic implications.
Violi F; Pignatelli P; Cammisotto V; Carnevale R; Nocella C
Kardiol Pol; 2021; 79(11):1197-1205. PubMed ID: 34847237
[TBL] [Abstract][Full Text] [Related]
42. Mechanisms of endothelial activation, hypercoagulation and thrombosis in COVID-19: a link with diabetes mellitus.
Valencia I; Lumpuy-Castillo J; Magalhaes G; Sánchez-Ferrer CF; Lorenzo Ó; Peiró C
Cardiovasc Diabetol; 2024 Feb; 23(1):75. PubMed ID: 38378550
[TBL] [Abstract][Full Text] [Related]
43. Interrelationship between COVID-19 and Coagulopathy: Pathophysiological and Clinical Evidence.
Ragnoli B; Da Re B; Galantino A; Kette S; Salotti A; Malerba M
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240292
[TBL] [Abstract][Full Text] [Related]
44. Thrombotic complications in children with Coronavirus disease 2019 and Multisystem Inflammatory Syndrome of Childhood.
Kumar R; Rivkin MJ; Raffini L
J Thromb Haemost; 2023 Sep; 21(9):2313-2326. PubMed ID: 37268064
[TBL] [Abstract][Full Text] [Related]
45. High D dimers and low global fibrinolysis coexist in COVID19 patients: what is going on in there?
Ibañez C; Perdomo J; Calvo A; Ferrando C; Reverter JC; Tassies D; Blasi A
J Thromb Thrombolysis; 2021 Feb; 51(2):308-312. PubMed ID: 32671609
[TBL] [Abstract][Full Text] [Related]
46. Elevated Plasma Soluble C-Type Lectin-like Receptor 2 Is Associated with the Worsening of Coronavirus Disease 2019.
Wada H; Ichikawa Y; Ezaki M; Yamamoto A; Tomida M; Yoshida M; Fukui S; Moritani I; Shiraki K; Shimaoka M; Iba T; Suzuki-Inoue K; Shimpo H
J Clin Med; 2022 Feb; 11(4):. PubMed ID: 35207258
[TBL] [Abstract][Full Text] [Related]
47. Long-term hypercoagulability, endotheliopathy and inflammation following acute SARS-CoV-2 infection.
Boccatonda A; Campello E; Simion C; Simioni P
Expert Rev Hematol; 2023; 16(12):1035-1048. PubMed ID: 38018136
[TBL] [Abstract][Full Text] [Related]
48. D-dimer: old dogmas, new (COVID-19) tricks.
Lippi G; Mullier F; Favaloro EJ
Clin Chem Lab Med; 2023 Apr; 61(5):841-850. PubMed ID: 35849562
[TBL] [Abstract][Full Text] [Related]
49. The role of anti-platelet factor 4 antibodies and platelet activation tests in patients with vaccine-induced immune thrombotic thrombocytopenia: Brief report on a comparison of the laboratory diagnosis and literature review.
Hsiao PJ; Wu KL; Chen YC; Chen YL; Wang RL; Wu KA; Chan JS; Chiu CC; Huang LY; Shyu HY; Kao YH; Chuu CP
Clin Chim Acta; 2022 Apr; 529():42-45. PubMed ID: 35167842
[TBL] [Abstract][Full Text] [Related]
50. Unusual pattern of thrombotic events in young adult non-critically ill patients with COVID-19 may result from an undiagnosed inherited and acquired form of thrombophilia.
Elbadry MI; Tawfeek A; Abdellatif MG; Salama EH; Abudeif A; Mahmoud H; Ezeldin M; Abdelkareem RM; Rashad UM
Br J Haematol; 2022 Feb; 196(4):902-922. PubMed ID: 34888860
[TBL] [Abstract][Full Text] [Related]
51. IL-1 induces throboxane-A2 (TxA2) in COVID-19 causing inflammation and micro-thrombi: inhibitory effect of the IL-1 receptor antagonist (IL-1Ra).
Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G; Toniato E
J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1623-1627. PubMed ID: 32744052
[TBL] [Abstract][Full Text] [Related]
52. Assessment of Coagulation Profiles by Rotational Thromboelastometry in COVID 19 Patients.
Elaa A; Syrine C; Haifa M; Walid N; Amene BB; Houyem SL; Ajmi C; Abderraouf O; Amina B
Clin Lab; 2022 Aug; 68(8):. PubMed ID: 35975495
[TBL] [Abstract][Full Text] [Related]
53. COVID-19 and coagulopathy.
Sarkar M; Madabhavi IV; Quy PN; Govindagoudar MB
Clin Respir J; 2021 Dec; 15(12):1259-1274. PubMed ID: 34399021
[TBL] [Abstract][Full Text] [Related]
54. Managing thrombosis and cardiovascular complications of COVID-19: answering the questions in COVID-19-associated coagulopathy.
Iba T; Levy JH; Connors JM; Warkentin TE; Thachil J; Levi M
Expert Rev Respir Med; 2021 Aug; 15(8):1003-1011. PubMed ID: 33667146
[TBL] [Abstract][Full Text] [Related]
55. Uncommon thrombotic complications after SARS-CoV-2 vaccination.
Musil D
Vnitr Lek; 2021; 67(5):297-302. PubMed ID: 35459396
[TBL] [Abstract][Full Text] [Related]
56. Early experience with arterial thromboembolic complications in patients with COVID-19.
Indes JE; Koleilat I; Hatch AN; Choinski K; Jones DB; Aldailami H; Billett H; Denesopolis JM; Lipsitz E
J Vasc Surg; 2021 Feb; 73(2):381-389.e1. PubMed ID: 32861865
[TBL] [Abstract][Full Text] [Related]
57. Variant-derived SARS-CoV-2 spike protein does not directly cause platelet activation or hypercoagulability.
Kusudo E; Murata Y; Kawamoto S; Egi M
Clin Exp Med; 2023 Nov; 23(7):3701-3708. PubMed ID: 37208552
[TBL] [Abstract][Full Text] [Related]
58. Brachial Artery Thrombosis in a Covid-19 Positive Patient with Thoracic Outlet Syndrome.
Heineman N; Koehler D
Iowa Orthop J; 2021 Dec; 41(2):1-5. PubMed ID: 34924863
[TBL] [Abstract][Full Text] [Related]
59. Splanchnic venous thrombosis in a nephrotic patient following COVID-19 infection: a case report.
Hussein MH; Alabdaljabar MS; Alfagyh N; Badran M; Alamiri K
BMC Nephrol; 2021 Dec; 22(1):420. PubMed ID: 34965863
[TBL] [Abstract][Full Text] [Related]
60. Complement activation and coagulopathy - an ominous duo in COVID19.
Tomo S; Kumar KP; Roy D; Sankanagoudar S; Purohit P; Yadav D; Banerjee M; Sharma P; Misra S
Expert Rev Hematol; 2021 Feb; 14(2):155-173. PubMed ID: 33480807
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
